Concurrently, activation of the transcription factor NF-κB in CNS cells such as T lymphocytes, macrophages, microglia, astrocytes, and oligodendrocytes amplifies neuroinflammation and drives MS pathogenesis [161]. This evidence concerns the gene NFKB1 and myeloid sarcoma.